Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus Mefloquine
NCT00970879 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 430
Last updated 2013-01-23
Summary
The purpose of this study is to evaluate the efficacy of cotrimoxazole prophylaxis in prevention of malaria during pregnancy in HIV-infected women, compared to intermittent preventive treatment with mefloquine.
Conditions
- Malaria in Pregnancy
- HIV Infections
Interventions
- DRUG
-
cotrimoxazole
800 mg sulfamethoxazole and 160 mg trimethoprim daily, from 28 weeks of gestation until delivery
- DRUG
-
mefloquine
mefloquine 15 mg/Kg three times, between 16 and 28 weeks, 24 and 32 weeks, then 28 and 36 weeks of pregnancy
Sponsors & Collaborators
-
Sidaction
collaborator OTHER -
Saint Antoine University Hospital
collaborator OTHER -
National University Hospital, Cotonou
collaborator OTHER -
Université d'Abomey-Calavi
collaborator OTHER -
Ministry of Health, Benin
collaborator OTHER_GOV -
Institut de Recherche pour le Developpement
lead OTHER_GOV
Principal Investigators
-
Marcel D Zannou, Professor · Cotonou University Hospital & Faculté des Sciences de la Santé, Benin
-
Pierre-Marie Girard, Professor · Saint Antoine Hospital, Assistance Publique-Hôpitaux se Paris
-
Michel Cot, MD, PHD · Institut de Recherche pour le Developpement
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-12-31
- Primary Completion
- 2012-07-31
- Completion
- 2012-12-31
Countries
- Benin
Study Locations
More Related Trials
-
Improving PRegnancy Outcomes With PReVEntive Therapy in Africa-2 (IMPROVE-2)
NCT04158713 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Study of Mefloquine and S-P as Prophylaxis Against Malaria in Pregnant HIV + Patients
NCT02524444 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial of Antimalarial Drugs Used in Pregnancy in Tanzania
NCT00146731 ·Status: COMPLETED ·Phase: PHASE3
-
Relationships Between the Use of Antimalarial Drugs in Pregnancy and Plasmodium Falciparum Resistance
NCT00140517 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetic of Mefloquine-Artesunate in Plasmodium Falciparum Malaria Infection in Pregnancy
NCT00701961 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Improving PRegnancy Outcomes With Intermittent preVEntive Treatment in Africa
NCT03208179 ·Status: COMPLETED ·Phase: PHASE3
-
Cotrifazid Safety and Efficacy Against Malaria
NCT00322907 ·Status: TERMINATED ·Phase: PHASE2
-
Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women With Uncomplicated Plasmodium Falciparum Infection
NCT01082718 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Comparison of Two Regimens of Artemether-lumefantrine for the Treatment of Malaria in Pregnancy
NCT01916954 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa
NCT01103063 ·Status: TERMINATED ·Phase: PHASE3
-
Monitoring Pregnant Women for Antimalarial Drug Resistance
NCT05072613 ·Status: COMPLETED
-
Chloroquine for Malaria in Pregnancy
NCT01443130 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparative Study of Azithromycin and S-P as Prophylaxis in Pregnant HIV+ Patients
NCT02527005 ·Status: COMPLETED ·Phase: PHASE1
-
Routine Antenatal Care Versus Screening and Treatment of Malaria in Pregnancy in Rwanda
NCT03508349 ·Status: COMPLETED ·Phase: NA
-
IPT of Malaria With SP in Different Zones of Drug Resistance in Rwanda
NCT00372632 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Chloroquine on HIV Viral Load Among Pregnant Women in Uganda
NCT00132535 ·Status: COMPLETED ·Phase: NA
-
Pregnant Women for Malaria Surveillance
NCT04412005 ·Status: COMPLETED
-
Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)
NCT03079388 ·Status: COMPLETED ·Phase: NA
-
Azithromycin Plus Chloroquine Versus Mefloquine In the Treatment of Uncomplicated P. Falciparum Malaria.
NCT00367653 ·Status: COMPLETED ·Phase: PHASE3
-
Controlled Human Malaria Infection (CHMI) After Immunization With Cryopreserved Plasmodium Falciparum Sporozoites Under Chloroquine Prophylaxis
NCT01728701 ·Status: COMPLETED ·Phase: PHASE1
-
Improving Neonatal Health Through Rapid Malaria Testing in Early Pregnancy With High-Sensitivity Diagnostics
NCT05757167 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
The ASPIRE Trial - Aiming for Safe Pregnancies by Reducing Malaria and Infections of the Reproductive Tract
NCT04189744 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Chemopreventive Regimens to Prevent Malaria and Improve Birth Outcomes in Uganda
NCT04336189 ·Status: COMPLETED ·Phase: PHASE3
-
Focal Mass Drug Administration for the Prevention of Malaria in Pregnancy
NCT07021430 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)
NCT02282293 ·Status: COMPLETED ·Phase: PHASE3